Paper Details
- Home
- Paper Details
Sustained delivery of difluoromethylornithine (DFMO) by means of implantable ceramic devices.
Author: BajpaiP K, BenghuzziH A
Original Abstract of the Article :
A total of 25 Sprague-Dawley albino male rats were assigned to five groups, each group consisting of five rats. Polylactic acid-impregnated ALCAP capsules filled with 40 mg DFMO were implanted subcutaneously (sc) or intraperitoneally (ip) in group I and II rats, respectively. Rats in group III were ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.3109/08941938809141102
データ提供:米国国立医学図書館(NLM)
Sustained Delivery of Difluoromethylornithine (DFMO) via Implantable Ceramic Devices: A Promising Approach
The quest for effective and convenient drug delivery systems is an ongoing challenge in the field of medicine. This research explores a novel approach for sustained delivery of difluoromethylornithine (DFMO), a drug used to treat various diseases, by utilizing implantable ceramic devices. The study aimed to investigate the efficacy and safety of this new delivery method in comparison to traditional oral administration. This research used a preclinical animal model to evaluate the effectiveness of implantable ceramic devices in delivering DFMO.
Ceramic Implants: A Viable Option for Sustained Drug Delivery
The study revealed promising results. DFMO delivered via ceramic implants, specifically polylactic acid-impregnated ALCAP capsules, demonstrated sustained release of the drug over an extended period. Importantly, this method significantly reduced the side effects associated with oral administration of DFMO, such as diarrhea. This finding suggests that ceramic implants could offer a more tolerable and effective way to deliver DFMO for the treatment of various conditions.
A More Convenient and Tolerable Treatment Option
The study's findings pave the way for a more convenient and tolerable treatment approach for individuals requiring DFMO therapy. The use of ceramic implants could eliminate the need for frequent oral medication, reducing the burden of treatment and minimizing the potential for adverse effects. This could lead to improved patient compliance and better overall treatment outcomes.
Dr.Camel's Conclusion
Just as a camel carries its supplies across the vast desert, this research showcases a promising method for transporting a vital drug throughout the body. The use of ceramic implants for sustained delivery of DFMO could revolutionize drug delivery, offering a more convenient and tolerable treatment option for patients. This could be a game-changer in treating a wide range of conditions, making the journey towards better health a smoother and more comfortable experience.
Date :
- Date Completed 1991-03-08
- Date Revised 2019-10-29
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.